HALBERT HARGROVE GLOBAL ADVISORS, LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1484205
LONG BEACH, CA
Position in ALNY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$301
-$10,187 QoQ
Shares Held
1
-95.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#783
of 784 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HALBERT HARGROVE GLOBAL ADVISORS, LLC holds $3,475 across 8 Biotechnology names. ALNY ranks #4 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2 | $993 | |
| 2 | ARGX |
Argenx SE
|
1 | $927 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1 | $623 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1 | $301 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1 | $240 | |
| 6 | INCY |
Incyte Corp
|
2 | $226 | |
| 7 | EXEL |
Exelixis, Inc.
|
2 | $108 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1 | $57 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301 | 1 | Shares | Sole | 2026-07-21 | |
| 2025-09-30 | $10,488 | 23 | Shares | Sole | 2025-10-16 | |
| 2025-03-31 | $270 | 1 | Shares | Sole | 2025-04-18 | |
| No filing history on record for this holder in this stock. | ||||||